These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24664319)

  • 1. Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy.
    Nagatomo Y; Meguro T; Ito H; Koide K; Anzai T; Fukuda K; Ogawa S; Yoshikawa T
    PLoS One; 2014; 9(3):e93145. PubMed ID: 24664319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
    Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial mineralocorticoid receptor ablation confers protection towards endothelial dysfunction in experimental diabetes in mice.
    Lyngsø KS; Jensen BL; Hansen PBL; Dimke H
    Acta Physiol (Oxf); 2022 Feb; 234(2):e13731. PubMed ID: 34519423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
    Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
    Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.
    Takata H; Takeda Y; Zhu A; Cheng Y; Yoneda T; Demura M; Yagi K; Karashima S; Yamagishi M
    Diabetes Obes Metab; 2012 Feb; 14(2):155-62. PubMed ID: 21951301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
    Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system.
    De Mello WC; Gerena Y
    Regul Pept; 2008 Nov; 151(1-3):54-60. PubMed ID: 18585409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
    Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
    Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
    Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
    Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization.
    Yamada M; Kushibiki M; Osanai T; Tomita H; Okumura K
    Cardiovasc Res; 2008 Jul; 79(1):169-78. PubMed ID: 18326554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
    Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
    Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy.
    Leung M; Wong VW; Heritier S; Mihailidou AS; Leung DY
    Cardiovasc Diabetol; 2013 Oct; 12():139. PubMed ID: 24083804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.